3Yarnada I, Mastsushima Y, Suzuki S. Moyamoya disease: diagnosis with Three - demensional time of flight MR angiography. Radiology,1992, 184:773 - 778.
4Maki Y, Enomoto T. Moyamoya disease. Child' s Nerve Syst, 1988,4:204 - 212.
5Koukin k, Takahashi A, Kamiyama H, et al. Familial occurrence of moyamoya disease: magnetic resonance angiography as a screening test for high -risk subjects. Nerv Syst, 1994,10: 421.
6Abe T, Matsumoto K. Magnetic resonance angiography of cerebral arteriovenous malfomations. Neurol Med Chir Tokyo, 1995, 35:580 - 583.
7Aoyagi M,Fukai N,Yamamoto M,et al.Early Development of Intimal Thickening in Superficial Temporal Arteries in Patients With Moyamoya Disease.Stroke,1996,27(10):1750-1754..
8Suzuki Y,Fujita M,Mizutani N,et al.Role of nitric oxide in the control of cerebral microcirculation under physiological and pathological condition.Clinical Hemorheology Microcirculation,2000,23(2-4):307-312.
9Noda A,Suzuki Y,Takayasu M,et al.Elevation of nitric oxide metabolites in the cerebrospinal fluid of patients with Moyamoya disease.Acta Neurochir(Wien),2000,142(11):1275-1280.
10Hoshimaru M,Takahashi JA,Kikuchi H,et al.Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease:an immunohistochemical study.J Neurosurg,1991,75(2):267-270.
共引文献73
1Jian-Feng Han1,Cheng-Tai Wang2,Jian-Bo Yang1,Feng Guo1,Zheng-Yi Li11. Department of Neurology,the First Affiliated Hospital,Medical School of Xi’an Jiaotong University,Xi’an 710061,2. No.2 Department of Neurology,Hospital of Chinese Traditional Medicine of Baoji,Baoji 721000,China..Clinical manifestations and cerebral angiographic findings of moyamoya disease[J].Journal of Pharmaceutical Analysis,2010,22(2):131-134.
2WILLINEK W A, BORN M, SIMON B, et al. Time -of- fight MR angiography: comparison of 3.0 - T imaging and 1.5 - T imaging - initial experience[ J ]. Radiology, 2003, 229 : 913 - 920.
3FUSHIMI Y, MIKI Y, KIKUTA K I. Comparisoti of 3.0 - and 1.5 - TThree - dimensional time - of - flight MR angiography in moyamoya disease : preliminary experience[ J]. Radiology, 2006, 239: 232 - 237.
4KOMIYAMA K, NAKAJIMA H, NISHIKAWA M, et al. Leptomeningeal contrast enhancement in moyamoya: its potential role in postoperative assessment of circulation throughthe bypass [ J ]. Neuroradiology, 2001,43 : 17 -23.
6MORIOKA M, HAMADA J I, TODAKA T. et al. High risk age for rebleeding In patients with hemorrhagic moyamoya disease: long_term follow_up study [ J ]. Neurosurgery, 2003, 52 ( 5 ) : 1 049 -1 055.
7UNQUEIRA P A, MOURA - RIBEIRO M V. Moyamoya and down syndrome : study conducted by meta - ananlysis [ J ]. Arq Neuropsiquiatr, 2002, 60(2-A): 274-280.
8YAMADA I, MATSUSHIMA Y, SUZUKIS. Moyamoya disease : Diagnosis with three - dimensional time - of - flight MR angiograph[J] . Radiology, 1992, 184:773-778.
9Seol HJ,Wang KC,Kim SK,et al.Familial occurrence of moyamoya disease:a clinical study[J].Childs Nerv Syst,2006,22(9):1143-1148.
10Girirajan S,Mendoza-Londono R,Vlangos CN,et al.Smith-Magenis syndrome and Moyamoya disease in a patient with del(17)(p11.2p13.1)[J].Am J Med Genet A,2007,143A(9):999-1008.
